CD44 and colorectal carcinoma: Our data show that the migratory phenotype of CRC cells is suppressed immediately following exposure to chemotherapeutic agents due to loss of CXCR4+ cells and elevation of CD26 peptidase; and this is associated with enrichment of a CD44+/CD133− cell subset.